Bitcoin ETF Flows: How to Identify BTC Support & Resistance
- Bitcoin ETF flows help identify potential BTC bottoms and resistance levels, but inflows and outflows alone cannot predict price reversals.
- ETF cost basis is a key price indicator. Estimates around $81,500–$82,000 in 2026 highlight an important zone where Bitcoin may encounter buying or selling pressure.
- Watch for confirmation signals. Shrinking outflows, positive 5-day or 30-day net flows, and price stability near the cost basis can suggest a potential local bottom.
- Large inflows don't guarantee a rally. Strong ETF buying can also occur near local tops, making price action, on-chain data, and broader market conditions essential cross-checks.
What Are Bitcoin ETF Flows and How Do They Affect BTC Price?
How to Identify Bitcoin Price Bottoms Using ETF Flows
- Outflows that no longer push price lower. In mid-October 2026, Bitcoin held the roughly $81,500 ETF cost basis twice even as the funds posted about $746 million in recent net outflows, according to Glassnode data reported by Pluang. When redemptions land and the level holds anyway, someone else is absorbing the supply.
- A test of the cost basis from above. Holders who are in profit at the line have less reason to sell there. If price dips into the zone and flows turn positive on the same days, the line is acting as support.
- A turn in the rolling flow, not a single day. A five-day or 30-day net flow flipping positive after a run of outflows says more than one green print. The week of October 19–25, 2026 broke a two-week outflow streak, though October as a whole was still net negative, per a weekly recap from Towards Finance.
How to Find Bitcoin Support and Resistance Levels Using ETF Flows
- Outflows into a rally. Between May 15 and May 29, 2026, spot Bitcoin ETFs lost $2.97 billion over ten straight sessions, a record streak, while price pushed toward a realized-price cluster near $86,900 left by buyers from November through February, according to CoinDesk and The Block figures compiled by KuCoin News.
- Inflows that shrink as price nears the level. In late September, daily inflows fell from $999 million on Monday to $134 million by Friday, and Bitcoin stayed capped beneath the $84,000–$85,000 area where many long-term holders had bought, per a Crypto.com market update.
Bitcoin ETF Cost Basis in 2026: Key Support and Resistance Levels
| Date | BTC price | Estimated ETF cost basis (model, date) | Flow context |
| Mid-Oct 2026 | Held ~$81,500 twice | ~$81,500 (Glassnode, reported Oct 13) | ~$746M in recent net outflows |
| Sep 21–22, 2026 | ~$86,000 (Sep 22) | $81,722 (Bloomberg Intelligence, Sep 21) | $999M on Sep 21 and $715M on Sep 22 (SoSoValue) |
| May 15–29, 2026 | Rally toward ~$86,900 | ~$86,900 realized-price cluster (The Block) | $2.97B out over ten sessions |
| Feb 12, 2026 | ~$66,171 | $84,063 (Bloomberg Intelligence, Feb 12) | 2026 net flows near –$2B |
Do Bitcoin ETF Inflows Signal a Price Bottom?
How to Confirm Bitcoin ETF Signals With On-Chain Data
- Short-term holder cost basis. The average entry price for coins bought in recent months was around $80,000, according to analyst commentary compiled by Pluang in mid-October. With that figure just under the ETF basis, the $80,000–$82,000 band had two groups of holders defending roughly the same breakeven.
- Exchange balances. Santiment noted in October that Bitcoin supply on exchanges was rising again after a sharp drop early in the month, though not at a pace that suggested a mass sell-off. Coins moving onto exchanges near a key level often mean holders are getting ready to sell into it.
- Derivatives calendar. Large options expiries, such as the roughly $12.3 billion in Bitcoin options scheduled for October 30, 2026 per Towards Finance, can pull price around a level for reasons that have nothing to do with ETF demand.
- Macro releases. Inflation and growth data, and the Fed decisions that respond to them, can move Bitcoin through a cost-basis band faster than flows can react.
Bitcoin ETF Flows FAQ: Inflows, Outflows and Cost Basis
About WEEX
Follow WEEX on social media
This content is provided for general informational purposes only and doesn't constitute financial, investment, legal, or tax advice. Any events, rewards, online promotions, or related information mentioned herein should not be considered a recommendation, solicitation, or invitation to purchase, sell, trade, or otherwise deal in any crypto assets. Crypto assets are highly volatile and may result in loss. The availability of WEEX services, products, and related events may vary by region. You are responsible for ensuring that your participation is in accordance with applicable local laws and regulations.
You may also like

Broadcom (AVGO) : AI Growth, Fund Positioning, and Guarantee Risk
Broadcom (AVGO) recently fell with the semiconductor sector, closing down 10.43% at $291.53 on November 5. The shares rebounded more than 4% in premarket trading on November 6. Concerns that election results could lead to tighter AI rules and slower data center approvals contributed to a broad sell-off, with a semiconductor index falling about 12%. The move appears tied mainly to sector sentiment and policy concerns, with no clear company-specific negative catalyst identified.
Institutional trading and AI growth expectations are also in focus. ARK funds sold about $134 million of Broadcom shares over two sessions while adding to SpaceX. Citi maintained its Buy rating and projected that Broadcom’s AI semiconductor revenue could reach $115 billion in fiscal 2027, roughly doubling year over year. Broadcom had approximately $179.2 billion in signed contracts as of the prior quarter, while analysts estimated fourth-quarter AI chip revenue at about $21.7 billion. These forecasts will need to be tested against future results.
Contingent guarantees are another point for investors to monitor. Broadcom is providing guarantees tied to Anthropic’s AI rack-leasing arrangement, involving about $29 billion in the first phase and a second-phase plan of up to $43 billion. Banks plan to issue $21 billion in bonds to support related chip financing. The guarantee amounts are not the same as debt already incurred, but they add a potential risk to assess. Broadcom is scheduled to report its next quarterly results on December 9, when management’s outlook for fiscal 2027 AI demand will be closely watched. This article is for informational purposes only and is not investment advice.

Netflix (NFLX) Stock Rebounds: Insider Sales, Advertising, and Growth Plans
Several Netflix executives sold company shares in early November 2026. Co-CEO Theodore Sarandos sold 27,312 shares from November 3 to 4, valued at about $1.81 million. CFO Spencer Neumann sold shares worth approximately $612,000. Co-CEO Gregory Peters realized about $1.69 million, including transactions related to tax withholding. Chief Legal Officer David Hyman and director Bradford Smith also reduced their holdings. Executive sales can have different reasons and should not be viewed on their own as a measure of the company’s outlook.
After recent pressure, Netflix shares rebounded more than 4% around November 4. Bill Ackman’s Pershing Square Capital Management allocated about 5% of its portfolio to Netflix, while new AI features and positive views on the company’s technology prospects helped sentiment. Netflix reported third-quarter 2026 revenue of $13.44 billion and earnings per share of $0.87, both above expectations, though its forward outlook remains a key focus.
Advertising is one of Netflix’s main challenges. Delays to key ad product features led the company to reduce its annual advertising revenue outlook from $3 billion to $2.7 billion. Viewer engagement has also faced pressure from changes in content appeal and competition from platforms such as YouTube. Netflix is pursuing growth through live events, gaming, and advertising, with plans to expand its ad-supported offering to 15 markets while adjusting its workforce by about 6% to improve margins. Investors may want to monitor advertising growth, engagement, and profitability. This article is for informational purposes only and is not investment advice.

Carvana Earnings: Record Sales, Strong Profit, and Insider Share Sales
Carvana reported third-quarter net revenue of $8.04 billion, up 42.4% year over year and above the $7.7 billion market estimate. Retail units sold reached a record 217,385, an increase of 39.4%. Net income rose to $483 million, while adjusted EBITDA reached a record $800 million, reflecting gains in both revenue and profitability.
Management expects full-year 2026 adjusted EBITDA to reach the upper end of its $2.7 billion to $3.0 billion range. Needham maintained its Buy rating, named Carvana a top pick in transportation technology, and set a $100 price target. Strong results and guidance have drawn investor attention, though continued performance will depend on sales, margins, and operating costs.
Insider transactions are also on investors’ radar. A regulatory filing indicates that CFO Mark Jenkins planned to sell 63,800 shares on November 2, 2026, valued at approximately $4.35 million. Since August, he has planned sales totaling 191,300 shares. An executive share sale alone does not determine a company’s outlook; investors may also consider earnings, cash flow, and future guidance. This article is for informational purposes only and is not investment advice.

FCEL Stock: Data Center Opportunity, Manufacturing Costs, and Lawsuit Risk
FuelCell Energy (ticker: FCEL) provides fuel-cell power solutions. Growing electricity demand from AI data centers could create new business opportunities, while proposed pauses on new data center approvals in some areas have raised concerns about project timelines. A 75-megawatt power project may be affected, and FCEL shares recently fell as much as about 17% in a single session amid policy concerns.
FCEL signed an agreement with Fit Energy to provide up to 380 megawatts of fuel-cell power solutions. Its backlog is approximately $3.6 billion, with about 97% of its sales pipeline related to data centers. The company also drew the second installment under a $49 million financing arrangement backed by an export credit agency, supporting a green energy project and clean-energy exports. Recent leadership changes include Matthew Latino becoming CFO, digital infrastructure executive Peter Hopper joining the board, and John Dansby leading manufacturing scale-up. Converting orders into revenue will depend on production capacity, costs, and project execution.
FCEL reported third-quarter revenue of about $33 million, down approximately 29% year over year, and a net loss of roughly $45.3 million. Product costs and manufacturing overhead for the Fit Energy agreement exceeded the contract pricing, resulting in an approximately $17 million contract impairment charge. Securities class-action allegations concern disclosures about manufacturing capacity and costs; the case remains in the legal process. The deadline to seek appointment as lead plaintiff is November 10, 2026. FCEL’s growth opportunities come with execution, financing, and litigation risks. This article is for informational purposes only and is not investment advice.

PFE Stock: Pfizer’s Q3 2026 Earnings, Business Strategy, and Dividend Outlook
PFE is the New York Stock Exchange ticker for Pfizer Inc. In the third quarter of 2026, Pfizer reported revenue of $16.58 billion and adjusted earnings per share of $0.87, both above market expectations. The company raised its full-year revenue outlook to $62 billion–$64 billion and its adjusted EPS guidance to $2.95–$3.05, pointing to stronger performance than previously expected.
Although demand for COVID-related products continues to decline, Pfizer’s non-COVID business is growing. Third-quarter sales reached $720 million for the cancer drug Padcev and $2.52 billion for Eliquis, up 25% year over year. Revenue from newer and acquired products rose 32%. Pfizer is expanding its oncology pipeline, entering the weight-loss treatment market through its acquisition of Metsera, and targeting approximately $9.7 billion in net cost savings by 2029. Cecile Guegan has also taken over as chief financial officer.
Investors are also watching Pfizer’s dividend and legal developments. The company declared a cash dividend of $0.43 per share, with an ex-dividend date of November 6, 2026. Analysts raised some earnings estimates and price targets following the quarterly results. Pfizer also faces ongoing legal scrutiny related to statements about COVID vaccine safety, while its subsidiary Mylan has sued Novo Nordisk over generic-drug patent issues involving Wegovy. Pfizer’s outlook depends on new-product growth, cost savings, patent matters, and litigation developments. This article is for informational purposes only and is not investment advice.

What Is TLT? Long-Term Treasury Bonds After the Midterm Election

A Look at the S&P 500 ETF After the Midterm Election

AI Trading: Start With a Review of Your Own Trades

CLARITY Act Faces Setback. Why Is Bitcoin Above $80K?

How Many iPhone 18 Pro Max Can 1 BTC Buy Right Now?

How Do Crypto Exchanges Build Security? A Look at WEEX’s Security Practices

AMD Earnings Preview: Can AI Demand Translate Into Stronger Margins?

Why Is AMD Stock Down 11%? What to Expect From Nov. 3 Earnings

After the October FOMC Meeting: What Could Drive Bitcoin and Stocks Next?

WEEX Dice Rush Stock Matchup Rules: How Winners Are Decided

Google Earnings Preview: What Would It Take to Lift the Stock?
What could lift Google stock after earnings? Review Alphabet’s Q3 expectations, Cloud margins and AI cash flow, and explore WEEX’s GOOGL prediction round.

FOMC Decision Oct 28, 2026: Scenarios for Stocks, Bitcoin and Gold

Bitcoin Price Ahead of October 28 Fed Decision: What 2026 Data Shows

Oil Pulls Back After Last Week’s Rally. What Does It Mean for Bitcoin and Stocks?

Google Earnings on Oct 28: Will the Fed Decision Move GOOGL Stock?

Meta Beat Earnings. Why Did Its Stock Fall 7%?

Zcash NU7 Upgrade: 3 Things ZEC Holders Must Know Before November 5

October 28: The Fed, Big Tech Earnings and What to Watch in Bitcoin, Stocks and Gold

Crypto Exchange Security in 2026: How to Verify WEEX Reserves and Protection Fund

Tesla Delivered More Cars Than Expected. Does That Mean It Made More Money?

Tokenized Stocks vs. Stock ETFs: What’s the Difference?

Why Is SpaceX Stock Down 34% From Its Peak? Q3 Earnings & Lockup Risks Ahead

What Is the Market Expecting From Tesla Q3 Earnings Now?

What's new on WEEX: TradFi, Telegram Mini App and Passkey Security
From accessing TradFi markets to discovering trading pairs, verifying account activity, and managing assets, these updates reflect a broader direction: making the different parts of trading work together more naturally.

Chips, AI and Bitcoin: Reading Cross-Market Risk Appetite After a Volatile Week
Broadcom (AVGO) : AI Growth, Fund Positioning, and Guarantee Risk
Broadcom (AVGO) recently fell with the semiconductor sector, closing down 10.43% at $291.53 on November 5. The shares rebounded more than 4% in premarket trading on November 6. Concerns that election results could lead to tighter AI rules and slower data center approvals contributed to a broad sell-off, with a semiconductor index falling about 12%. The move appears tied mainly to sector sentiment and policy concerns, with no clear company-specific negative catalyst identified.
Institutional trading and AI growth expectations are also in focus. ARK funds sold about $134 million of Broadcom shares over two sessions while adding to SpaceX. Citi maintained its Buy rating and projected that Broadcom’s AI semiconductor revenue could reach $115 billion in fiscal 2027, roughly doubling year over year. Broadcom had approximately $179.2 billion in signed contracts as of the prior quarter, while analysts estimated fourth-quarter AI chip revenue at about $21.7 billion. These forecasts will need to be tested against future results.
Contingent guarantees are another point for investors to monitor. Broadcom is providing guarantees tied to Anthropic’s AI rack-leasing arrangement, involving about $29 billion in the first phase and a second-phase plan of up to $43 billion. Banks plan to issue $21 billion in bonds to support related chip financing. The guarantee amounts are not the same as debt already incurred, but they add a potential risk to assess. Broadcom is scheduled to report its next quarterly results on December 9, when management’s outlook for fiscal 2027 AI demand will be closely watched. This article is for informational purposes only and is not investment advice.
Netflix (NFLX) Stock Rebounds: Insider Sales, Advertising, and Growth Plans
Several Netflix executives sold company shares in early November 2026. Co-CEO Theodore Sarandos sold 27,312 shares from November 3 to 4, valued at about $1.81 million. CFO Spencer Neumann sold shares worth approximately $612,000. Co-CEO Gregory Peters realized about $1.69 million, including transactions related to tax withholding. Chief Legal Officer David Hyman and director Bradford Smith also reduced their holdings. Executive sales can have different reasons and should not be viewed on their own as a measure of the company’s outlook.
After recent pressure, Netflix shares rebounded more than 4% around November 4. Bill Ackman’s Pershing Square Capital Management allocated about 5% of its portfolio to Netflix, while new AI features and positive views on the company’s technology prospects helped sentiment. Netflix reported third-quarter 2026 revenue of $13.44 billion and earnings per share of $0.87, both above expectations, though its forward outlook remains a key focus.
Advertising is one of Netflix’s main challenges. Delays to key ad product features led the company to reduce its annual advertising revenue outlook from $3 billion to $2.7 billion. Viewer engagement has also faced pressure from changes in content appeal and competition from platforms such as YouTube. Netflix is pursuing growth through live events, gaming, and advertising, with plans to expand its ad-supported offering to 15 markets while adjusting its workforce by about 6% to improve margins. Investors may want to monitor advertising growth, engagement, and profitability. This article is for informational purposes only and is not investment advice.
Carvana Earnings: Record Sales, Strong Profit, and Insider Share Sales
Carvana reported third-quarter net revenue of $8.04 billion, up 42.4% year over year and above the $7.7 billion market estimate. Retail units sold reached a record 217,385, an increase of 39.4%. Net income rose to $483 million, while adjusted EBITDA reached a record $800 million, reflecting gains in both revenue and profitability.
Management expects full-year 2026 adjusted EBITDA to reach the upper end of its $2.7 billion to $3.0 billion range. Needham maintained its Buy rating, named Carvana a top pick in transportation technology, and set a $100 price target. Strong results and guidance have drawn investor attention, though continued performance will depend on sales, margins, and operating costs.
Insider transactions are also on investors’ radar. A regulatory filing indicates that CFO Mark Jenkins planned to sell 63,800 shares on November 2, 2026, valued at approximately $4.35 million. Since August, he has planned sales totaling 191,300 shares. An executive share sale alone does not determine a company’s outlook; investors may also consider earnings, cash flow, and future guidance. This article is for informational purposes only and is not investment advice.
FCEL Stock: Data Center Opportunity, Manufacturing Costs, and Lawsuit Risk
FuelCell Energy (ticker: FCEL) provides fuel-cell power solutions. Growing electricity demand from AI data centers could create new business opportunities, while proposed pauses on new data center approvals in some areas have raised concerns about project timelines. A 75-megawatt power project may be affected, and FCEL shares recently fell as much as about 17% in a single session amid policy concerns.
FCEL signed an agreement with Fit Energy to provide up to 380 megawatts of fuel-cell power solutions. Its backlog is approximately $3.6 billion, with about 97% of its sales pipeline related to data centers. The company also drew the second installment under a $49 million financing arrangement backed by an export credit agency, supporting a green energy project and clean-energy exports. Recent leadership changes include Matthew Latino becoming CFO, digital infrastructure executive Peter Hopper joining the board, and John Dansby leading manufacturing scale-up. Converting orders into revenue will depend on production capacity, costs, and project execution.
FCEL reported third-quarter revenue of about $33 million, down approximately 29% year over year, and a net loss of roughly $45.3 million. Product costs and manufacturing overhead for the Fit Energy agreement exceeded the contract pricing, resulting in an approximately $17 million contract impairment charge. Securities class-action allegations concern disclosures about manufacturing capacity and costs; the case remains in the legal process. The deadline to seek appointment as lead plaintiff is November 10, 2026. FCEL’s growth opportunities come with execution, financing, and litigation risks. This article is for informational purposes only and is not investment advice.
PFE Stock: Pfizer’s Q3 2026 Earnings, Business Strategy, and Dividend Outlook
PFE is the New York Stock Exchange ticker for Pfizer Inc. In the third quarter of 2026, Pfizer reported revenue of $16.58 billion and adjusted earnings per share of $0.87, both above market expectations. The company raised its full-year revenue outlook to $62 billion–$64 billion and its adjusted EPS guidance to $2.95–$3.05, pointing to stronger performance than previously expected.
Although demand for COVID-related products continues to decline, Pfizer’s non-COVID business is growing. Third-quarter sales reached $720 million for the cancer drug Padcev and $2.52 billion for Eliquis, up 25% year over year. Revenue from newer and acquired products rose 32%. Pfizer is expanding its oncology pipeline, entering the weight-loss treatment market through its acquisition of Metsera, and targeting approximately $9.7 billion in net cost savings by 2029. Cecile Guegan has also taken over as chief financial officer.
Investors are also watching Pfizer’s dividend and legal developments. The company declared a cash dividend of $0.43 per share, with an ex-dividend date of November 6, 2026. Analysts raised some earnings estimates and price targets following the quarterly results. Pfizer also faces ongoing legal scrutiny related to statements about COVID vaccine safety, while its subsidiary Mylan has sued Novo Nordisk over generic-drug patent issues involving Wegovy. Pfizer’s outlook depends on new-product growth, cost savings, patent matters, and litigation developments. This article is for informational purposes only and is not investment advice.





